Boost your Grades with us today!
NURS 6521 Week 9 Discussion: Pharmacotherapy for Hematologic Disorders
Sample Answer for NURS 6521 Week 9 Discussion: Pharmacotherapy for Hematologic Disorders Included After Question
As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes?
For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.
RESOURCES
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
WEEK 9 RESOURCES
WEEK 10 RESOURCES
To Prepare:
- Review the Resources for this module and reflect on the different health needs and body systems presented.
- Your Instructor will assign you a complex case study to focus on for this Discussion.Links to an external site.
- Consider how you will practice critical decision making for prescribing appropriate drugs and treatment to address the complex patient health needs in the patient case study you selected.
BY DAY 3 OF WEEK 9
Post a brief description of your patient’s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.
You will respond to your colleagues’ posts in Week 10.
Note: For this Discussion, you are required to complete your initial post before you will be able to view and respond to your colleagues’ postings. Begin by clicking on the Reply button to complete your initial post. Remember, once you click on Post Reply, you cannot delete or edit your own posts and you cannot post anonymously. Please check your post carefully before clicking on Post Reply!
BY DAY 6 OF WEEK 10
Read a selection of your colleagues’ responses from Week 9 and respond to at least two of your colleagues on two different days who were assigned a different patient case study, and provide recommendations for alternative drug treatments to address the patient’s pathophysiology. Be specific and provide examples.
Discussion: Pharmacotherapy for Hematologic Disorders
In the 1970s, the average lifespan for patients diagnosed
with sickle cell disease was 14 years. Today, the average lifespan has
increased to 50 years and beyond (TriHealth, 2012). The patient prognosis for
many other hematologic disorders such as hemophilia and cancer continue to
improve as well. This can be attributed to advancements in medical care—specifically
drug therapy and treatment. When managing drug therapies for patients, it is
essential to continuously examine current treatments and evaluate the impact of
patient factors on drug effectiveness. To prepare for your role as an advanced
practice nurse, you must become familiar with common drug treatments for
various hematologic disorders seen in clinical settings.
To prepare:
Select one of the following hematologic disorders: anemia,
hemophilia, cancer, sickle cell anemia, thalassemia, thrombolytic disorders, or
white blood cell disorders. Consider the types of drugs that would be
prescribed to patients to treat symptoms associated with this disorder.
Select one of the following factors: genetics, gender,
ethnicity, age, or behavior. Reflect on how this factor might impact the
effects of prescribed drugs, as well as any measures you might take to help
reduce negative side effects.
With these thoughts in mind:
By Day 3
Post a description of the hematologic disorder you selected
including types of drugs that would be prescribed to patients to treat
associated symptoms. Then, explain how the factor you selected might impact the
effects of prescribed drugs, as well as any measures you might take to help
reduce negative side effects.
By Day 6
Read a selection of your colleagues’ responses and respond
to at least two of your colleagues on two different days who selected a
different hematologic disorder than you did. Provide recommendations for
alternative drug treatments and patient education strategies for treatment and
management.
A Sample Answer For the Assignment: NURS 6521 Week 9 Discussion: Pharmacotherapy for Hematologic Disorders
Title: NURS 6521 Week 9 Discussion: Pharmacotherapy for Hematologic Disorders
In this Case study, a 46-year-old patient comes to the clinic with complaints of night sweats, hot flushing, and genitourinary problems. The patient presents with signs of menopause. Headaches sleep issues, mood swings, vasomotor symptoms including hot flashes and night sweats, and anxiety may occur throughout this time because of the decreased ovarian activity and fluctuations of hormone levels (Taebi et al., 2018). Patient also presents a history of ASCUS, which is atypical cells found in the tissue lining the cervix’s outer portion. ASCUS can be a sign of low hormone levels, which may occur in menopausal women. According to a 2018 study, the incidence of ASCUS was highest in women who were menstruation normally (Misra et al., 2018)
The diagnosis of perimenopause would be given to this patient. For women experiencing perimenopausal and menopausal symptoms, Hormonal Replacement Therapy (HRT) is thought to be an appropriate treatment option. However, the patient has hypertension as well as a family history of breast cancer. A treatment plan should be personalized based on the patient’s past medical history, Thus, HRT would not be beneficial for this patient as it increases the risk of breast cancer and increases blood pressure.
The treatment plan would be to manage the patient’s symptoms. Since we are avoiding HRT, antidepressants would be prescribed to reduce night sweats and improve vasomotor symptoms. SSRIs would be prescribed to help manage the patient’s symptoms, such as Citalopram. Non-hormonal medications such as clonidine, gabapentin, pregabalin, and antidepressants may be a significant effective therapy for vasomotor symptoms (Karanth et al., 2019). To treat her genitourinary symptoms, transdermal estrogen therapy would be beneficial, which is applied directly on the skin and easily absorbs the hormone in systemic circulation. This would be a safer option for such high-risk patients as a transdermal patch bypasses the first pass effect and makes the blood estrogen levels lower than oral administration. A low dose of estrogen would suffice with topical administration.
Side effects and benefits should be discussed with the patient before prescribing the medications. Education on the side effects of Citalopram, such as dizziness, sleepiness, and headache, will be provided. Also, the patient would be educated on adhering to both medication regimens to improve her symptoms over time. The patient will also be educated on monitoring her blood pressure and reporting any adverse effects.
Taebi, M., Abdolahian, S., Ozgoli, G., Ebadi, A., & Kariman, N. (2018, July 6). Strategies to improve menopausal quality of life: A systematic review. Journal of education and health promotion. Retrieved January 23, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052783/
Misra, J. S., Srivastava, A. N., & Zaidi, Z. H. (2018). Cervical cytopathological changes associated with onset of Menopause. Journal of mid-life health. Retrieved January 23, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332728/
Karanth, L., Chuni, N., & Nair, N. S. (2019, September 12). Antidepressants for menopausal symptoms. The Cochrane Database of Systematic Reviews. Retrieved January 24, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739239/
A Sample Answer 2 For the Assignment: NURS 6521 Week 9 Discussion: Pharmacotherapy for Hematologic Disorders
Title: NURS 6521 Week 9 Discussion: Pharmacotherapy for Hematologic Disorders
As correctly stated in the discussion, the patient is presented with the signs and symptoms of perimenopause. Perimenopause is a time of menstrual transition. Menstrual transition is when most women begin to get signs and symptoms of menopause. Therefore, the patient needs to be exposed to a treatment that will ease her transition into menopause. As illustrated in the discussion, subjecting the patient to hormone replacement therapy (HRT) is impossible. The perfect solution is to present the patient with a low dose of estrogen combined with progestin. Combining these hormones will help control the patient’s perimenopause symptoms (Roberts & Hickey, 2016). The patient history of hypertension justifies using estrogen and progestin to help eliminate symptoms that include fever, hot flushing, and all the genitourinary symptoms (Rosenthal & Burchum, 2021). The dangers of the treatment proposed are anchored on taking tablets. As a result, the treatment can be offered in the format of injection, eliminating the possible spike of hypertension or the possibility of suffering cancer.
The patient is currently on Norvasc treatment for hypertension. Norvasc treatment is perfect for hypertension and, therefore, cannot be altered (Misra, Srivastava, & Zaidi, 2018). An important aspect to discuss is the use of SSRI to manage the patient’s symptoms, which include hot flushing and fevers.
There is little to no evidence that classes of antidepressants, including SSRIs, contribute to eliminating or preventing symptoms like migraine, headaches, and vomiting. As a result, it would be risky to subject the patient to SSRI as a model of symptom control. A perfect recommendation would be to offer the patient serotonin. The serotonin 1b/1d agonists (triptans) inhibit the release of vasoactive peptides, promote vasoconstriction, and block pain pathways in the brainstem migraine. Even other primary headaches and secondary headaches may also improve with triptan treatment. Serotonin is known to cause vasoconstriction of the nerve endings, thereby eliminating the patient’s pain, including headaches (Schwedt & Garza, 2022). The patient can take Fluoxetine to manage her symptoms. In terms of patient education, the patient can be subjected to an analysis of the side effects of the injected estrogen. She can also be taught effective ways to manage her hypertension. The discussion above illustrates alternative treatments that can help the patient recover. The patient’s pathophysiology, pharmacological conditions, and possible drugs influence the proposed treatment.
References
Misra, JS., Srivastava, AN., & Zaidi, ZH. (2018). Cervical cytopathological changes associated with onset of menopause. Journal of mid-life health. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332728/Links to an external site.
Schwedt, TJ., & Garza, I. (2022). Acute treatment of migraine in adults. In RP. Goddeau (Ed.). UpToDate. https://www.uptodate.com/contents/acute-treatment-of-migraine-in-adults?search=serotonin%20and%20headache&topicRef=3348&source=related_linkLinks to an external site.
Roberts, H., & Hickey, M. (2016). Managing the menopause: An update. Maturitas, 86, p53-58 https://doi.org/10.1016/j.maturitas.2016.01.007 Links to an external site..
Rosenthal, LD. & Burchum, JR. (2021. Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants – E-Book. Elsevier Health Sciences. Kindle Edition.
A Sample Answer 3 For the Assignment: NURS 6521 Week 9 Discussion: Pharmacotherapy for Hematologic Disorders
Title: NURS 6521 Week 9 Discussion: Pharmacotherapy for Hematologic Disorders
Case Study 1
One of the patient’s health needs would be to continue with the antibiotics as a priority. In addition, this patient needs nutrition assessment and treatment, considering that he does not tolerate a diet. Malnutrition comes with high complications in admitted patients, and parental nutrition is used in case oral and enteral feeding is challenging. In case the patient cannot tolerate a diet, TPN should be considered as it is a high risk in patients with known infection (Comerlato, Stefani, Viana & Viana, 2020). TPN is high in sugar content, and infection usually feeds on sugar. As the patient is also diabetic, the blood sugar also needs to be checked every six hours.
The penicillin allergy should also be considered, as the patient is covered with Ceftriaxone and azithromycin until his sputum and blood cultures results are determined. Cultures are critical to helping effectively cover and treat specific infections. Blood cultures are vital specimens managed by microbiology laboratories. It is also a primary and very sensitive technique for diagnosing bloodstream infections. The sputum and blood culture results will guide the provider on starting medication. The nutrition team will also assess the patient to determine whether he is a candidate for TPN or NG/OG.
In inpatient education, it is essential to conduct thorough awareness of the importance of nutrition and compliance with the allocated medication. The patient has to be prepped for success before discharge. The nurse and provider must be certain that the patient appreciates the importance of the home care plan (Rosenthal & Burchum, 2021). The plan has to comprise adequate knowledge of nutritional needs to meet at home and ways to deter community-based infections. It is also critical to educate the patient on the importance of follow-ups with the primary care provider to be sure he is adhering to the home care plan.
References
Comerlato, P. H., Stefani, J., Viana, M. V., & Viana, L. V. (2020). Infectious complications associated with parenteral nutrition in intensive care unit and non-intensive care unit patients. Brazilian Journal of Infectious Diseases, 24(2), 137–143. https://doi-org.ezp.waldenulibrary.org/10.1016/j.bjid.2020.02.002Links to an external site.
Rosenthal, L. D. & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier
Grading Rubric Guidelines
Performance Category | 10 | 9 | 8 | 4 | 0 |
Scholarliness
Demonstrates achievement of scholarly inquiry for professional and academic decisions. |
|
|
|
|
|
Performance Category | 10 | 9 | 8 | 4 | 0 |
Application of Course Knowledge –
Demonstrate the ability to analyze, synthesize, and/or apply principles and concepts learned in the course lesson and outside readings and relate them to real-life professional situations |
|
|
|
|
|
Performance Category | 5 | 4 | 3 | 2 | 0 |
Interactive Dialogue
Replies to each graded thread topic posted by the course instructor, by Wednesday, 11:59 p.m. MT, of each week, and posts a minimum of two times in each graded thread, on separate days. (5 points possible per graded thread) |
|
Summarizes what was learned from the lesson, readings, and other student posts for the week. |
|
|
|
Minus 1 Point | Minus 2 Point | Minus 3 Point | Minus 4 Point | Minus 5 Point | |
Grammar, Syntax, APA
Note: if there are only a few errors in these criteria, please note this for the student in as an area for improvement. If the student does not make the needed corrections in upcoming weeks, then points should be deducted. Points deducted for improper grammar, syntax and APA style of writing. The source of information is the APA Manual 6th Edition |
|
|
|
|
|
0 points lost | -5 points lost | ||||
Total Participation Requirements
per discussion thread |
The student answers the threaded discussion question or topic on one day and posts a second response on another day. | The student does not meet the minimum requirement of two postings on two different days | |||
Early Participation Requirement
per discussion thread |
The student must provide a substantive answer to the graded discussion question(s) or topic(s), posted by the course instructor (not a response to a peer), by Wednesday, 11:59 p.m. MT of each week. | The student does not meet the requirement of a substantive response to the stated question or topic by Wednesday at 11:59 pm MT. |